Briefly, 10 μl of PBS, liver cancer mouse serum, SD liver cancer mouse serum, SD liver cancer mouse serum plus CTLA-4 inhibitors were added separately into a 96-well plate with HepG2 cells. This evidence concerns the gene CTLA4 and liver cancer.